A case report abstract is not a shorter version of a standard IMRaD research abstract. It summarizes a single patient’s presentation, diagnosis, treatment, and outcome rather than a study’s methods and results, and the leading reporting standard for it — the CARE Guidelines — specifies its own four-part structure that differs from the Background/Methods/Results/Conclusions pattern used for original research. This guide walks through that structure and works through one fully labeled, illustrative example.
How a Case Report Abstract Differs from a Research-Paper Abstract
A standard structured research abstract reports on a study: a research question, a method applied across a sample or dataset, results, and a conclusion. A case report abstract reports on one clinical case: what happened to a specific patient, what made it noteworthy, and what the field can learn from it. The underlying logic is different. A research abstract is judged on methodological rigor and generalizability; a case report abstract is judged on whether the case is genuinely novel, instructive, or reveals something (an unusual presentation, an unexpected complication, a diagnostic pitfall) that existing literature does not already cover. Journals that publish case reports typically expect authors to state that novelty explicitly, in the abstract itself — something a conventional research abstract has no equivalent requirement for.
This also distinguishes a case report abstract from a conference abstract, which follows whatever structure the conference’s call for abstracts specifies and can summarize any kind of work (a study, a case, a protocol, a quality-improvement project). A case report abstract’s structure is fixed by the case-reporting literature itself, most influentially the CARE Guidelines, regardless of the venue.
The CARE Guidelines: What They Require of the Abstract
The CARE (CAse REport) Guidelines are a consensus-based reporting standard for clinical case reports, first published by Gagnier, Kienle, Altman, Moher, Sox, and Riley in Journal of Medical Case Reports in 2013 (and co-published in several other journals the same year), with an accompanying explanation-and-elaboration document and a periodically updated checklist. CARE’s checklist runs to 13 reporting items covering the whole case report — title, key words, abstract, introduction, patient information, clinical findings, timeline, diagnostic assessment, therapeutic intervention, follow-up and outcomes, discussion, patient perspective, and informed consent.
Item 3, the abstract, is broken into four required sub-elements:
- 3a — Introduction: what is unique about this case and what it adds to the medical literature.
- 3b — Main symptoms and important clinical findings.
- 3c — Main diagnoses, therapeutic interventions, and outcomes.
- 3d — Conclusion: the primary “take-away” lesson(s) from the case.
Many journals that require or recommend CARE compliance (a substantial share of biomedical case-report venues do, either explicitly in their author guidelines or by cross-reference to the EQUATOR Network) expect these four elements to be identifiable in the abstract even when the journal doesn’t use CARE’s exact subheadings. Some journals ask for them as explicit labeled subheadings; others expect the same four moves made within an unstructured paragraph. Always check the target journal’s own instructions for authors before assuming either format.
Section-by-Section Structure
1. Introduction / novelty statement
One to two sentences establishing why this specific case is worth publishing: an unusual presentation of a common condition, a rare condition, an unexpected treatment response, a previously undescribed complication, or a diagnostic lesson. This is the sentence an editor and a reader use to decide whether the case is genuinely additive to the literature, so it should be specific rather than a generic claim of rarity.
2. Patient information and clinical findings
The patient’s relevant demographic and clinical context (age, sex, and relevant history, kept to what is clinically necessary rather than identifying) and the presenting symptoms and examination or investigation findings that led to the diagnostic workup.
3. Diagnosis, intervention, and outcome
What diagnosis was reached and how (the key diagnostic finding or test), what treatment or intervention followed, and what happened as a result — including the follow-up period, since an outcome reported without a stated follow-up duration is hard for a reader to weigh.
4. Conclusion / take-away
The lesson a reader should carry away: a diagnostic pattern to watch for, a treatment consideration, or a gap in current understanding the case illustrates. This is not a restatement of the introduction — it is the practical implication.
Word Limits and Formatting
Case report abstracts are typically shorter than original-research abstracts, commonly in a roughly 150-300 word range, but the exact limit, and whether structured subheadings are required, is set by each individual journal and varies enough that there is no universal figure to rely on. Some journals impose case-report-specific word limits distinct from their general abstract limit; some case-report-only journals (for example those indexed as dedicated case-report venues) allow more latitude than a general medical journal’s case-report section. Confirm the current instructions for authors on the target journal’s own site before finalizing length and format — this is the same practical caution that applies to any abstract word-limit question generally.
Worked Example
Introduction: Drug-induced hypoglycemia from a non-diabetes medication is easily overlooked in an emergency setting when the presenting patient is not known to have diabetes. We describe a case that illustrates this diagnostic blind spot and the value of a full medication reconciliation in unexplained hypoglycemia.
Patient information and clinical findings: A composite adult patient presented to an emergency department with confusion and diaphoresis. Point-of-care glucose was markedly low. The patient had no prior diagnosis of diabetes and was not on any glucose-lowering therapy according to the initial history.
Diagnosis, intervention, and outcome: A more detailed medication reconciliation, obtained after initial glucose correction, identified recent use of a non-diabetes medication with a known but under-recognized hypoglycemic side effect. The medication was discontinued, glucose was monitored over an extended observation period, and no further hypoglycemic episodes occurred during follow-up.
Conclusion: Unexplained hypoglycemia in a non-diabetic patient warrants a full medication history, including agents not typically associated with glucose effects, before the workup is expanded to rarer endocrine causes.
Notice what each part is doing structurally: the introduction states novelty (a diagnostic blind spot, not just “an interesting case”), the middle two sections separate what was found from what was done and what resulted, and the conclusion states a transferable lesson rather than simply repeating that the patient improved.
Case Report Abstracts vs. Case Series Abstracts
A case report describes a single patient. A case series aggregates a small number of patients (commonly framed as more than one, often fewer than about ten to twenty depending on the journal) sharing a common feature, and its abstract is written differently: it reports findings in aggregate (how many patients, what proportion showed a given feature or outcome) rather than following one patient’s individual timeline through diagnosis and outcome. CARE’s own checklist covers single case reports; case series more commonly draw on general observational-study reporting conventions in addition to, or instead of, CARE.
Patient Consent and Ethical Considerations
Because a case report describes an identifiable individual’s health information, both CARE and the ICMJE Recommendations require documented patient consent for publication, and many journals ask authors to state in the manuscript (and sometimes explicitly in the abstract or a consent statement accompanying it) that this consent was obtained. This is a substantive requirement, not a formality: identifying details are removed or generalized specifically so the patient cannot be recognized by people other than themselves, even when consent has been given.
Frequently Asked Questions
Does a case report abstract need labeled subheadings like Background/Methods/Results?
Not necessarily the same labels as a research abstract. CARE specifies four content elements (introduction/novelty, findings, diagnosis-intervention-outcome, conclusion) but leaves it to the journal whether those are presented as explicit subheadings or woven into an unstructured paragraph. Follow the target journal’s instructions for authors.
How long should a case report abstract be?
There is no single universal limit; it varies by journal and is commonly shorter than a full research-paper abstract. Check the specific journal’s current word-count requirement rather than assuming a figure.
Is CARE compliance mandatory?
It depends on the journal. Many biomedical journals that publish case reports require or strongly recommend CARE compliance, and some ask authors to submit the completed CARE checklist alongside the manuscript, but this is a journal-level editorial policy rather than a universal mandate across all publishers.
Do I need patient consent to publish a case report abstract if the case is de-identified?
De-identification does not remove the consent requirement under CARE or ICMJE guidance for case reports describing an identifiable individual’s clinical course. Documented patient consent for publication is expected regardless of how thoroughly identifying details have been generalized.
